MARK E. DELANEY - 04 Mar 2026 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)

Role
SVP & Chief Commercial Officer
Signature
Sean D. Mersten, Attorney in Fact for Mark E. Delaney
Issuer symbol
DGX
Transactions as of
04 Mar 2026
Net transactions value
$0
Form type
4
Filing time
06 Mar 2026, 16:44:45 UTC
Previous filing
04 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
DELANEY MARK E SVP & Chief Commercial Officer 500 PLAZA DRIVE, C/O QUEST DIAGNOSTICS INC, SECAUCUS Sean D. Mersten, Attorney in Fact for Mark E. Delaney 06 Mar 2026 0001955265

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DGX Common Stock Award +5,682 +67% $204.86* 14,190 04 Mar 2026 Direct F1
transaction DGX Common Stock Tax liability -2,326 -16% $204.86* 11,864 04 Mar 2026 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award approved in accordance with the requirements of Rule 16b-3(d).
F2 Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award.